Industries > Pharma > Cell Therapy Technologies Market Report 2021-2031

Cell Therapy Technologies Market Report 2021-2031

Forecasts by Product (Consumables, Equipment, Systems & Software), by Cell Type (T-Cells, Stem Cells, Other Cells), by Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), End-user (Biopharmaceutical & Biotechnology Companies and CROs, Research Institutes and Cell Banks) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell Therapy Technologies Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 10 March 2021
PAGES: 314
PRODUCT CODE: PHA1119
SUBMARKET: Biotechnology

Clear
WOOCS 2.2.1
SKU: PHA1119 Categories: , Tags: , , ,

Growing Focus on Precision Medicine to Offer Lucrative Growth Opportunities Over the Next Decade
Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burden and the need for more personalized & precision medicine has led to massive growth in the cell therapy technologies market, which is likely to increase over the next decade. While the global market will experience significant growth, the Asia Pacific region is expected to be the fastest growing submarket, primarily due to the presence of large numbers of clinical research organizations (CROs) in the region.

Technological Advancements Anticipated to Fuel Cell Therapy Technologies Market
Cell therapy technology is one of the fastest growing markets and is an ever-changing landscape. It represents the umbrella of recent advancement in the field of gene therapy, drug delivery, cancer vaccines, various application of stem cells, regenerative medicine, and tissue engineering. Higher government investments for cell-based research, availability of advanced cell therapy technologies and growing demand of cell therapies are expected to further propel the market growth.

UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

To access the data contained in this document please email contactus@visiongain.com

Which Factors are Fueling Cell Therapy Technologies Industry Growth?
• Rising incidence of chronic & infectious diseases
• Large number of oncology-related cell therapy clinical trials
• Increasing GMP certifications for cell therapy production facilities
• Rising government initiatives towards cell-based research activities

Which Factors are Restraining Growth?
• Dearth of skilled professionals
• High cost of cell-based research & low success rate

What are the Market Opportunities?
• Increasing public-private partnerships for the development of cell therapies
• Emergence of iPSCs as an alternative to ESCs
• Emerging economies across Asia Pacific region

How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.

Discover how to stay ahead
Our 310+ page report provides 310+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cell Therapy Technologies Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Product
• Consumables
• Equipment
• Systems & Software

Cell Type
• T-Cells
• Stem Cells
• Other Cells

Process
• Cell Processing
• Cell Preservation, Distribution, and Handling
• Process Monitoring and Quality Control

End-User
• Biopharmaceutical & Biotechnology Companies
• CROs, Research Institutes and Cell Banks

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:

By Region

• North America
– U.S.
– Canada

• Europe
– Germany
– UK
– France
– Italy
– Spain
– Rest of Europe

• Asia Pacific
– China
– Japan
– India
– Australia
– Rest of Asia Pacific

• Rest of the World
– Brazil
– Mexico
– GCC
– Rest of RoW

Cell Therapy Technologies Market Report 2021-2031
Need industry data? Please contact us today.

Leading companies and the potential for market growth
Overall world revenue for Cell Therapy Technologies Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which regions hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 12 of the major companies involved in the Cell Therapy Technologies Market. Some of the companies profiled in this report include Thermo Fisher Scientific, Merck KGaA, Lonza, Danaher, STEMCELL Technologies Inc., Sartorius AG, TERUMO BCT, INC., Fresenius Medical Care AG & Co. KGaA, Avantor, Inc., BD, CellGenix GmbH, and Sirion-Biotech GmbH.

Key Questions Answered by this Report:
• What is the current size of the overall global cell therapy technologies market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall Cell Therapy Technologies market over the next ten years?
• What are the main segments within the overall cell therapy technologies market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world cell therapy technologies? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Which are the leading companies and what are their activities, results, developments, and prospects?
• What are the main trends that will affect the world cell therapy technologies market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• How will the global cell therapy technologies market evolve over the forecasted period, 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is intended for everybody needing commercial analyses for the Global Cell Therapy Technologies Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Cell Therapy Technologies Market Report 2021-2031: Forecasts by Product (Consumables, Equipment, Systems & Software), by Cell Type (T-Cells, Stem Cells, Other Cells), by Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), End-user (Biopharmaceutical & Biotechnology Companies and CROs, Research Institutes and Cell Banks) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell Therapy Technologies Companies AND COVID-19 Recovery Scenarios
. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Cell Therapy Technologies Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for Cell Therapy Technologies Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories